Centre hospitalier Emile Roux
- Address
- lock Available on a paid plan
Centre hospitalier Emile Roux - Ophthalmology and Inflammatory Disease Research
Centre hospitalier Emile Roux conducts specialized research in the field of ophthalmological inflammatory conditions, with a particular focus on optimizing treatment strategies for complex autoimmune disorders affecting the eye. The center demonstrates expertise in personalized medicine approaches, utilizing advanced therapeutic monitoring techniques to improve patient outcomes while minimizing treatment-related risks.
- Non-infectious chronic uveitis treatment optimization
- Therapeutic drug monitoring (TDM) for biologic therapies
- De-escalation strategies in autoimmune ophthalmological diseases
The center's research emphasizes innovative approaches to managing non-infectious uveitis using adalimumab, a biologic therapy, with particular attention to developing evidence-based protocols for treatment spacing based on therapeutic drug monitoring. This work aims to balance achieving sustained remission with reducing treatment burden and infection risks in patients with chronic inflammatory eye conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre hospitalier Emile Roux
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunosuppressive Therapy Discontinuation Versus Maintenance in ANCA-Associated Vasculitis with End-Stage Renal Disease: A Randomized Multicenter Trial | Centre Hospitalier Departemental Vendee | Phase I | Not Recruiting | Feb 2018 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adalimumab | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.